Click here for more information about Algenuity
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology Check out more of The Buzz spacer

Dr. Craig Behnke joins Lumen Bioscience as SVP

July 16, 2018
AlgaeIndustryMagazine.com

Dr. Craig Behnke has joined Lumen Bioscience as Senior Vice President, Production and Development.

Lumen Bioscience, a Seattle company developing novel biologics on its proprietary spirulina expression platform, has announced that Dr. Craig Behnke has joined its executive team as Senior Vice President, Production and Development.

Dr. Behnke will assume leadership of Lumen’s existing production and development teams. He joins as Lumen launches its first product, RioBlue™, a high-purity protein extract used as a blue colorant by the food and cosmetics industries. Dr. Behnke previously served as Vice President of Research and Development at Sapphire Energy in San Diego, a pioneer in the industrial-scale cultivation of photosynthetic microbes.

“We are pleased to welcome Dr. Behnke to Lumen’s senior leadership team,” said Brian Finrow, Lumen’s CEO and co-founder. “Craig’s experience makes him the perfect leader to scale commercial production beyond our current facility in Seattle. His scientific background and history of scaling up biological systems at Sapphire will be invaluable as we continue to expand our capacity.”

Used first as a nutritional supplement for its naturally high protein, vitamin and antioxidant content, US spirulina extract sales soared after 2014 when the FDA approved it for use as a natural food colorant. Today it remains the only approved natural blue food pigment in the US, and is used mainly as a natural alternative to FD&C Blue #1, an artificial food colorant that is synthesized from petroleum.

“I am thrilled to be joining such a talented group of scientists, engineers, and quality professionals,” Dr. Behnke said. “This team has built a robust, integrated, cGMP-compliant production system to produce the highest possible quality product. They’ve laid a great foundation as we look to scale production to meet global demand over the next 24-36 months. Over the course of my career I have had the good fortune to participate in some remarkable achievements in bio-process yield improvement, and I’m excited to help unlock the enormous commercial potential of this fascinating new platform.” Dr. Behnke holds a Ph.D. in Biochemistry from the University of Washington and an M.S. in Biochemistry from Kansas State.

In addition to its core colorants business, Lumen has also won research funding to use its new platform to develop ultra-low-cost biologic drugs and vaccines, all of which rely upon the same integrated, FDA cGMP production platform. In May, the National Institutes of Health awarded Lumen a grant to continue developing its oral malaria vaccine, and last month Lumen announced additional research funding from the United States Department of Agriculture and the Bill & Melinda Gates Foundation for other vaccine and antibody research programs.

More Buzz…

Copyright ©2010-2019 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Trade Arabia reports that the Oman Centre for Marine Biotechnology (OCMB) recently signed a memorandum of understanding with Swedish Algae Factory to support the domestic...
42 Technology has been appointed by LabXero, acoustic particle filtration technology company, to help develop pilot-scale biomanufacturing equipment that could significan...
Cody Nelson writes for MPRNews.org that a team of University of Minnesota-Duluth researchers wanted to know how shortening winters — and less ice cover on lakes — might i...
Israeli-based Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health New Zealand, Ltd. (Supreme) to supply the rapidly growing markets in Ch...
French researchers have been exploring the potential of algae for boosting the immune systems of animals and reducing the use of antibiotics in livestock farming. Past st...
Researchers at Los Alamos National Laboratory and partner institutions have provided the first published report of algae using raw plants as a carbon energy source. The r...
Sophie Kevany writes in Decanter.com that a group of vineyards in France’s Bordeaux and Cognac regions are exploring whether algae can be used to prevent the fungal infec...
Dartmouth scientists have created a more sustainable feed for aquaculture by using a marine microalga co-product as a feed ingredient. The study is the first of its kind ...
Alexander Richter writes in thinkgeoenergy.com that Israel-based Algaennovation last week signed a 15-year contract with Icelandic energy utility and operator ON Power fo...
San Diego, CA and Kailua-Kona, HI-based Cellana, Inc. has signed an Asset Purchase Agreement with Cyanotech Corporation for the sale of Cellana’s six-acre production and ...
Mazda U.K. has announced that they are currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promo...
Paris-based Solabia Group (“Solabia”) has acquired Algatech Ltd., a global leader in the development, cultivation and commercialization of ingredients delivered from micr...